
Dr. Erika Haydu
@erikahaydu
#Lymphoma physician and clinical investigator @MGHCancerCenter, by way of @MGH @DanaFarber @BrighamWomens @ColumbiaPS @WilliamsCollege | views my own
ID: 1042943833619787776
21-09-2018 01:09:21
106 Tweet
384 Followers
385 Following

Great article Sachin H. Jain, MD, MBA about Brigham and Women's Hospital IM residency program leader @DrJoelKatz who "recruit[ed] for talent and heart... Heart for patients, heart for community, heart for colleagues"


Looking forward to this ASH trainee council podcast series #womeninhematology Becky Zon, MD and others @BloodJournal Blood Advances


Researchers from Mass General Cancer Center and colleagues find liso-cel as a second-line treatment for early relapsed or refractory LBCL, in a The Lancet study. pubmed.ncbi.nlm.nih.gov/35717989/


Congrats Becky Zon, MD #ASH22

Great presentation Christine Ryan, MD #ASH22



Excellent study looking at PROs with CART P. Connor Johnson #ASH22


Very interesting work in CH by Lachelle Dawn #ASH22

Excited to see this in print! Irun Bhan MassGeneral Medicine MassGeneral News

Amazing experience thanks Lymphoma Research Foundation, organizers, mentors, and my fellow scholars!

Love my Brigham residency family! Brigham and Women's Medicine Residents Brigham and Women's Hospital

Join Gaby Hobbs, MD, Dr. Erika Haydu, MD, PhD, Mark Leick, MD, P. Connor Johnson, MD, and Jacob Soumerai, MD in Boston for this leukemia/lymphoma OncLive.com event! Register now: bit.ly/3seljVt

